Ascendis Pharma
ASND
ASND
138 hedge funds and large institutions have $5.41B invested in Ascendis Pharma in 2019 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 41 increasing their positions, 41 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
34% more funds holding
Funds holding: 103 → 138 (+35)
3.98% more ownership
Funds ownership: 95.41% → 99.39% (+4%)
0% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 41
Holders
138
Holding in Top 10
19
Calls
$230M
Puts
$145M
Top Buyers
| 1 | +$141M | |
| 2 | +$89.9M | |
| 3 | +$65.7M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$65.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$57.6M |
Top Sellers
| 1 | -$58.9M | |
| 2 | -$42.5M | |
| 3 | -$37.5M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$21.8M |
| 5 |
First Manhattan
New York
|
-$19.8M |